Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
7/1/1990
1.
Phase II Study of Antiemesis with MDM (Midazolam/Dexamethasone/Metoclopramide) in Patients Receiving High-Dose Cisplatin (Summary Last Modified 07/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Completed
18 and over
MSKCC-88143
NCI-V89-0039
Last Modified:
9/10/2008
 
First Published:
7/6/2007
2.
Phase I Randomized Study of Garlic Supplements to Modulate Opioid Effects in Healthy Volunteers
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Natural history/Epidemiology
Closed
21 to 45
NCI
FHCRC-2040.00
FHCRC-2040.00, FHCRC-2040.00p, NCT00499460
Last Modified:
8/1/1990
3.
Trial of Antiemetic Therapy with MDM (Midazolam/Dexamethasone/Metoclopramide) in Patients Receiving Cisplatin for Malignancies (Summary Last Modified 08/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Completed
18 and over
MSKCC-89098
NCI-V89-0193
4.
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Closed
18 and over
Other
07-000848
NCT00578214
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute